Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic AMN patients,~* 18-64 years old,~* male and female,~* clinically and biochemically diagnosed;~* females must be obligated heterozygotes or must have gene mutation identified.~Exclusion Criteria:~* Pregnant and lactation in females,~* Cerebral inflammatory disease with cognitive disorder, and/or~* need the help of two walking sticks,~* epilepsy,~* hypersensibility to cysteine related compounds,~* transaminases 2 fold up normal values.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- N-acetylcysteine, lipoic acid and vitamin E (Type: EXPERIMENTAL): Two Dose titration design

Based on this trial design, predict the completion outcome and termination type (if applicable).